212 related articles for article (PubMed ID: 34620213)
21. UK clinicians' attitudes towards the application of molecular diagnostics to guide antibiotic use in ICU patients with pneumonias: a quantitative study.
Stewart SF; Pandolfo AM; Moon Z; Jani Y; Brett SJ; Brealey D; Singh S; Enne VI; Livermore DM; Gant V; Horne R
J Antimicrob Chemother; 2024 Jan; 79(1):123-127. PubMed ID: 37970680
[TBL] [Abstract][Full Text] [Related]
22. Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia.
Peiffer-Smadja N; Bouadma L; Mathy V; Allouche K; Patrier J; Reboul M; Montravers P; Timsit JF; Armand-Lefevre L
Crit Care; 2020 Jun; 24(1):366. PubMed ID: 32560662
[TBL] [Abstract][Full Text] [Related]
23. Molecular point-of-care testing for lower respiratory tract pathogens improves safe antibiotic de-escalation in patients with pneumonia in the ICU: Results of a randomised controlled trial.
Poole S; Tanner AR; Naidu VV; Borca F; Phan H; Saeed K; Grocott MPW; Dushianthan A; Moyses H; Clark TW
J Infect; 2022 Dec; 85(6):625-633. PubMed ID: 36096312
[TBL] [Abstract][Full Text] [Related]
24. Study protocol for a multicentre, cluster randomised, superiority trial evaluating the impact of computerised decision support, audit and feedback on antibiotic use: the COMPuterized Antibiotic Stewardship Study (COMPASS).
Catho G; De Kraker M; Waldispühl Suter B; Valotti R; Harbarth S; Kaiser L; Elzi L; Meyer R; Bernasconi E; Huttner BD
BMJ Open; 2018 Jun; 8(6):e022666. PubMed ID: 29950480
[TBL] [Abstract][Full Text] [Related]
25. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.
Pugh R; Grant C; Cooke RP; Dempsey G
Cochrane Database Syst Rev; 2011 Oct; (10):CD007577. PubMed ID: 21975771
[TBL] [Abstract][Full Text] [Related]
26. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
[TBL] [Abstract][Full Text] [Related]
27. Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT.
Barratt S; Bielicki JA; Dunn D; Faust SN; Finn A; Harper L; Jackson P; Lyttle MD; Powell CV; Rogers L; Roland D; Stöhr W; Sturgeon K; Vitale E; Wan M; Gibb DM; Sharland M
Health Technol Assess; 2021 Nov; 25(60):1-72. PubMed ID: 34738518
[TBL] [Abstract][Full Text] [Related]
28. Development of antibiotic treatment algorithms based on local ecology and respiratory surveillance cultures to restrict the use of broad-spectrum antimicrobial drugs in the treatment of hospital-acquired pneumonia in the intensive care unit: a retrospective analysis.
De Bus L; Saerens L; Gadeyne B; Boelens J; Claeys G; De Waele JJ; Benoit DD; Decruyenaere J; Depuydt PO
Crit Care; 2014 Jul; 18(4):R152. PubMed ID: 25030270
[TBL] [Abstract][Full Text] [Related]
29. An antibiotic stewardship programme to reduce inappropriate antibiotic prescribing for acute respiratory infections in rural Chinese primary care facilities: study protocol for a clustered randomised controlled trial.
Zhuo C; Wei X; Zhang Z; Hicks JP; Zheng J; Chen Z; Haldane V; Walley J; Guan Y; Xu H; Zhong N
Trials; 2020 May; 21(1):394. PubMed ID: 32398065
[TBL] [Abstract][Full Text] [Related]
30. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
[TBL] [Abstract][Full Text] [Related]
31. Prevention of early ventilation-acquired pneumonia (VAP) in comatose brain-injured patients by a single dose of ceftriaxone: PROPHY-VAP study protocol, a multicentre, randomised, double-blind, placebo-controlled trial.
Dahyot-Fizelier C; Frasca D; Lasocki S; Asehnoune K; Balayn D; Guerin AL; Perrigault PF; Geeraerts T; Seguin P; Rozec B; Elaroussi D; Cottenceau V; Guyonnaud C; Mimoz O;
BMJ Open; 2018 Oct; 8(10):e021488. PubMed ID: 30341115
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia as part of a macro-project funded by the Seventh Framework Program of the European Commission studying off-patent antibiotics: study protocol for a randomized controlled trial.
Rosso-Fernández C; Garnacho-Montero J; Antonelli M; Dimopoulos G; Cisneros JM;
Trials; 2015 Mar; 16():102. PubMed ID: 25872790
[TBL] [Abstract][Full Text] [Related]
33. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
[TBL] [Abstract][Full Text] [Related]
34. Evaluating probiotics for the prevention of ventilator-associated pneumonia: a randomised placebo-controlled multicentre trial protocol and statistical analysis plan for PROSPECT.
Johnstone J; Heels-Ansdell D; Thabane L; Meade M; Marshall J; Lauzier F; Duan EH; Zytaruk N; Lamarche D; Surette M; Cook DJ;
BMJ Open; 2019 Jun; 9(6):e025228. PubMed ID: 31227528
[TBL] [Abstract][Full Text] [Related]
35. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
[TBL] [Abstract][Full Text] [Related]
36. Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trials.
Weiss E; Essaied W; Adrie C; Zahar JR; Timsit JF
Crit Care; 2017 Jun; 21(1):162. PubMed ID: 28655326
[TBL] [Abstract][Full Text] [Related]
37. Effect of Gram Stain-Guided Initial Antibiotic Therapy on Clinical Response in Patients With Ventilator-Associated Pneumonia: The GRACE-VAP Randomized Clinical Trial.
Yoshimura J; Yamakawa K; Ohta Y; Nakamura K; Hashimoto H; Kawada M; Takahashi H; Yamagiwa T; Kodate A; Miyamoto K; Fujimi S; Morimoto T
JAMA Netw Open; 2022 Apr; 5(4):e226136. PubMed ID: 35394515
[TBL] [Abstract][Full Text] [Related]
38. A quasi-experimental study of a bundled diagnostic stewardship intervention for ventilator-associated pneumonia.
Albin OR; Troost JP; Saravolatz L; Thomas MP; Hyzy RC; Konkle MA; Weirauch AJ; Dickson RP; Rao K; Kaye KS
Clin Microbiol Infect; 2024 Apr; 30(4):499-506. PubMed ID: 38163481
[TBL] [Abstract][Full Text] [Related]
39. Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial (CAPNOR).
Serigstad S; Ritz C; Faurholt-Jepsen D; Markussen D; Ebbesen MH; Kommedal Ø; Bjørneklett RO; Heggelund L; Clark TW; van Werkhoven CH; Knoop ST; Ulvestad E; Grewal HMS;
Trials; 2022 Aug; 23(1):622. PubMed ID: 35915452
[TBL] [Abstract][Full Text] [Related]
40. Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial.
Muller M; Lefebvre F; Harlay ML; Glady L; Becker G; Muller C; Aberkane O; Tawk M; Julians M; Romoli A; Hecketsweiler S; Schneider F; Pottecher J; Chamaraux-Tran TN
Trials; 2021 Feb; 22(1):131. PubMed ID: 33573681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
